Archives

The National Toxicology Program at the National Institute of Environmental Health Sciences requests available data and information on approaches and/or technologies currently used to identify substances with the potential to cause excessive inflammation or exaggerated immune responses leading to tissue injury when swallowed, inhaled, or absorbed through the skin. Submitted information will be used to […]

“Dermal Technology Laboratory (DTL) has been awarded one of the most coveted accolades in UK business. In recognition of its international growth and success over the past five years. DTL, based at Keele University Science and Innovation Park has received a Queen’s Award for Enterprise.” “Dermal Technology Laboratory specialises in in vitro dermal absorption studies that […]

The European Chemicals Agency has published guidance on the use of alternatives to animal testing to fulfill REACH dossier obligations. The Guidance is targeted toward small and medium enterprises (SMEs) and intended to provide guidance in time for the 2o18 deadline. The deadline of 31 May 2018 concerns companies that manufacture or import substances in […]

Fifty-nine participants from 15 countries attended a workshop on “Developmental Neurotoxicity (DNT): the use of non-animal test methods for regulatory purposes” in Brussels. The event, co-organised by the Organisation for Economic Co-operation and Development (OECD) and the European Food Safety Authority (EFSA), focused on opportunities and challenges related to alternative methods for testing and assessing […]

Source: http://grants.nih.gov/grants/guide/rfa-files/RFA-TR-16-017.html Title: Microphysiological Systems (MPS) for Disease Modeling and Efficacy Testing (UG3/UH3)  Funding Opportunity Announcement: RFA-TR-16-017 Purpose The purpose of the Microphysiological Systems (MPS) for Disease Modeling and Efficacy Testing Program is to develop highly reproducible and translatable in vitro models for preclinical efficacy studies through discovery and validation of translatable biomarkers, development of […]

IIVS Releases Training Video to Replace Animals in Testing For Immediate Release Media Contact: Laura Henning 240-454-8459 lhenning@iivs.org GAITHERSBURG, MD – October 12, 2016 – Funded by a grant from the European Partnership for Alternative Approaches to Animal Testing (EPAA), the Institute for In Vitro Sciences, Inc.(IIVS) has released a technical training video that describes […]

Especially for our European colleagues, notice of an upcoming symposium organized by the newly created Netherlands National Committee for the protection of animals used for scientific purposes (NCad) on December 8, 2016 in Brussels –registration ends Nov 1. From the program description: “The purpose of this symposium is to discuss whether the current animal use […]

NICEATM and the PETA International Science Consortium (PISC) organized an expert meeting on “Alternative Approaches for Acute Inhalation Toxicity Testing to Address Global Regulatory and Non-regulatory Data Requirements.” Participants in the meeting, held September 22-23, 2016, in Bethesda, MD, identified four key activities needed to reduce and replace animal use for required inhalation toxicity testing: […]

Raymond Tice, former NICEATM Deputy Director and National Toxicology Program (NTP) Biomolecular Screening Branch chief, received the William and Eleanor Cave Award from the Alternatives Research and Development Foundation (ARDF). The William and Eleanor Cave Award is given to recognize contributions to advancing alternatives to the use of animals in testing, research, or education. The […]

The Scientific Advisory Committee for Alternative Toxicological Methods, which advises NICEATM and ICCVAM, met at the National Institute of Environmental Health Sciences in Research Triangle Park, NC, on September 27. ICCVAM agencies outlined a roadmap for the replacement of animals for the six most commonly used acute toxicity tests: ocular and dermal irritation; dermal sensitization; […]

Grant Opportunity title: Develop Novel Platforms to Accelerate Contraceptive Drug Discovery (Round 18) Source: http://gcgh.grandchallenges.org/challenge/develop-novel-platforms-accelerate-contraceptive-drug-discovery-round-18 Deadline: 9 Nov 2016 – 11:30am PST The Challenge While access to a range of appropriate and desirable contraceptive methods can have a broad beneficial impact on the lives of women, men and their families, this goal is currently not […]

Francois Busquet, CAAT Academy The CAAT Academy training program for 2017 has been published. The following sessions will be offered: Organs-on-a-chip @MIMETAS, Leiden (NL) In vitro skin & eye models – Part 1 @VUB, Brussels (BE) Liver models and AOP @Biopredic International, Rennes (FR) EDC in vitro models @Biodetection Systems, Amsterdam (NL) ADME @KUL, Leuven […]

Catherine Willett, HSUS From the European Commission: The Organisation for Economic Co-operation and Development (OECD) has recently published the first five adverse outcome pathways (AOP), three of which have been developed by the JRC. The AOPs are novel knowledge management tools in toxicology and are useful for supporting risk assessment to human health. They are […]